Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.030
0.00 (0.00%)
At close: Oct 15, 2026, 4:00 PM EDT
1.030
0.00 (-0.01%)
After-hours: Oct 15, 2026, 4:46 PM EDT
Immuron Employees
As of June 30, 2026, Immuron had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees increased by 1 or 14.29% compared to the previous year.
Employees
8
Change (1Y)
1
Growth (1Y)
14.29%
Revenue / Employee
$667,036
Profits / Employee
-$318,229
Market Cap
8.04M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 8 | 1 | 14.29% | 7 | 1 |
| Jun 30, 2025 | 7 | 0 | - | 7 | 0 |
| Jun 30, 2024 | 7 | 1 | 16.67% | 7 | 0 |
| Jun 30, 2023 | 6 | 1 | 20.00% | 6 | 0 |
| Jun 30, 2022 | 5 | - | - | 5 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 41 |
| CollPlant Biotechnologies | 39 |
| Bolt Biotherapeutics | 23 |
| Lisata Therapeutics | 21 |
| Moleculin Biotech | 17 |
| Lantern Pharma | 16 |
| BioVie | 13 |
| MetaVia | 8 |
IMRN News
- 2 days ago - Immuron Reports Phase 2 Travelan Results Published In Scientific Reports; Stock Down - Nasdaq
- 2 days ago - Immuron’s Travelan Phase 2 study results published - TheFly
- 2 days ago - Travelan® Phase 2 Study Results Published - GlobeNewsWire
- 5 weeks ago - Immuron To Launch PROIBS In U.S. After Australia Debut; Pre-market Shares Up - Nasdaq
- 5 weeks ago - Immuron to launch Proibs in the U.S. - TheFly
- 5 weeks ago - Immuron to launch PROIBS® in the United States - GlobeNewsWire
- 6 weeks ago - Immuron FY26 Revenue Rises 6% As Net Loss Narrows And Cash Surges - Nasdaq
- 3 months ago - Immuron FY26 Sales - Four Consecutive Quarters of Growth over Prior Year - GlobeNewsWire